ホーム › がん（全種類） › ミシガン州 › Ann Arbor
Ann Arbor、MIにおけるがん（全種類）の臨床試験
Ann Arborとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する25件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of ASP3082 in Adults With Advanced Solid Tumors
被験者募集中第1相
- Trinity Health Ann Arbor Hospital, Ypsilanti · 7マイル先
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
被験者募集中観察研究
- University of Michigan, Ann Arbor
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
被験者募集中第1相
- University of Michigan, Ann Arbor
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- University of Michigan Health System, Ann Arbor
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
被験者募集中第3相
- Quetzal Site 22, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Trinity Health Ann Arbor Hospital, Ann Arbor
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- University Of Michigan Comprehensive Cancer Center, Ann Arbor
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
被験者募集中第2相
- University of Michigan, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
被験者募集中第1/2相
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- University of Michigan, Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- University of Michigan, Ann Arbor
Prostate Active Surveillance Study
被験者募集中観察研究
- University of Michigan, Ann Arbor
Lurbinectedin in FET-Fused Tumors
被験者募集中第1/2相
- University of Michigan, Ann Arbor
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- C S Mott Children's Hospital, Ann Arbor
Abatacept in Immune Checkpoint Inhibitor Myocarditis
被験者募集中第3相
- University of Michigan, Ann Arbor
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
被験者募集中第2相
- C.S. Mott Children's Hospital, Ann Arbor
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- 他6件
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
被験者募集中第2相
- University of Michigan Health System - Ann Arbor /ID# 273511, Ann Arbor
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- University of Michigan/Mott Children's Hospital, Ann Arbor
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
被験者募集中第1相
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Suprachoroidal Administration in Subjects With Metastases to the Choroid
被験者募集中第2相
- Kellogg Eye Center, Ann Arbor
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
被験者募集中
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Ann Arbor
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- University of Michigan Medical Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18マイル先
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY109件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Durham, NC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- Arlington, VA48件の研究
Ann Arborにおける他の研究
- 乳がん27件の研究
- 前立腺がん27件の研究
- 非小細胞肺癌26件の研究
- 肺がん23件の研究
- 大腸癌23件の研究
- 心不全22件の研究
- 急性骨髄性白血病17件の研究
- 心血管疾患16件の研究
- 膵臓がん14件の研究
- 悪性黒色腫12件の研究
- 脳卒中12件の研究
- 頭頸部扁平上皮癌12件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。